Xyrem Settlement Gets Green Light
A federal judge on Friday approved Jazz Pharmaceuticals Inc.'s $20 million settlement with the federal government over an investigation into the promotion of Xyrem, a narcolepsy treatment containing oft-abused GHB, by...To view the full article, register now.
Already a subscriber? Click here to view full article